Daiwa Securities Group Inc. Sarepta Therapeutics, Inc. Transaction History

Daiwa Securities Group Inc.

$22.4 Billion
Q4 2024

A detailed history of Daiwa Securities Group Inc. transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Daiwa Securities Group Inc. holds 2,147 shares of SRPT stock, worth $163,880. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,147

Previous 3,929 45.36%

Holding current value

$163,880

Previous $490,000 46.73%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 07, 2025	SELL	$104.54 - $137.94 $186,290 - $245,809	-1,782 Reduced 45.36%	2,147 $261,000
Q3 2024 Nov 12, 2024	BUY	$124.33 - $156.75 $59,056 - $74,456	475 Added 13.75%	3,929 $490,000
Q2 2024 Aug 07, 2024	BUY	$113.33 - $163.85 $87,377 - $126,328	771 Added 28.74%	3,454 $546,000
Q1 2024 May 02, 2024	SELL	$93.7 - $141.53 $2,717 - $4,104	-29 Reduced 1.07%	2,683 $348,000
Q4 2023 Jan 31, 2024	SELL	$67.31 - $124.76 $6,125 - $11,353	-91 Reduced 3.25%	2,712 $262,000
Q3 2023 Nov 01, 2023	BUY	$102.5 - $123.59 $56,990 - $68,716	556 Added 24.74%	2,803 $340,000
Q2 2023 Jul 31, 2023	BUY	$106.4 - $157.19 $14,896 - $22,006	140 Added 6.64%	2,247 $257,000
Q1 2023 May 02, 2023	SELL	$117.53 - $155.99 $145,972 - $193,739	-1,242 Reduced 37.09%	2,107 $291,000
Q4 2022 Feb 06, 2023	BUY	$100.86 - $132.13 $3,933 - $5,153	39 Added 1.18%	3,349 $434,000
Q3 2022 Nov 02, 2022	SELL	$75.71 - $119.24 $6,132 - $9,658	-81 Reduced 2.39%	3,310 $366,000
Q2 2022 Aug 09, 2022	SELL	$62.69 - $88.44 $15,547 - $21,933	-248 Reduced 6.82%	3,391 $254,000
Q1 2022 Apr 29, 2022	SELL	$63.15 - $90.42 $1,705 - $2,441	-27 Reduced 0.74%	3,639 $284,000
Q4 2021 Feb 03, 2022	SELL	$77.28 - $99.42 $36,089 - $46,429	-467 Reduced 11.3%	3,666 $330,000
Q3 2021 Nov 05, 2021	BUY	$65.97 - $92.48 $9,301 - $13,039	141 Added 3.53%	4,133 $382,000
Q2 2021 Aug 06, 2021	SELL	$69.38 - $86.75 $197,108 - $246,456	-2,841 Reduced 41.58%	3,992 $310,000
Q1 2021 May 03, 2021	SELL	$72.25 - $168.95 $14,522 - $33,958	-201 Reduced 2.86%	6,833 $509,000
Q4 2020 Feb 04, 2021	SELL	$125.56 - $178.74 $105,721 - $150,499	-842 Reduced 10.69%	7,034 $1.2 Million
Q3 2020 Nov 02, 2020	SELL	$127.12 - $172.34 $115,552 - $156,657	-909 Reduced 10.35%	7,876 $1.11 Million
Q1 2020 May 14, 2020	SELL	$82.38 - $131.64 $15,322 - $24,485	-186 Reduced 2.07%	8,785 $860,000
Q4 2019 Jan 31, 2020	SELL	$76.53 - $135.58 $11,402 - $20,201	-149 Reduced 1.63%	8,971 $1.16 Million
Q3 2019 Nov 04, 2019	BUY	$72.81 - $156.91 $180,641 - $389,293	2,481 Added 37.37%	9,120 $686,000
Q2 2019 Jul 24, 2019	SELL	$112.21 - $151.95 $24,237 - $32,821	-216 Reduced 3.15%	6,639 $1.01 Million
Q1 2019 Apr 26, 2019	SELL	$106.67 - $151.68 $45,548 - $64,767	-427 Reduced 5.86%	6,855 $817,000
Q4 2018 Feb 05, 2019	BUY	$97.32 - $148.76 $673,941 - $1.03 Million	6,925 Added 1939.78%	7,282 $795,000
Q1 2018 May 02, 2018	BUY	$54.02 - $82.27 $19,285 - $29,370	357 New	357 $26,000

Others Institutions Holding SRPT

# of Institutions

534

Shares Held

85.3M

Call Options Held

1.55M

Put Options Held

1.35M

View Full List

About Sarepta Therapeutics, Inc.

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $6.68B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

More about SRPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Daiwa Securities Group Inc., based on Form 13F filings with the SEC.

News

Stay updated on Daiwa Securities Group Inc. with notifications on news.

Account

Daiwa Securities Group Inc. Sarepta Therapeutics, Inc. Transaction History